Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
Aon
AON
|
+$1.04B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$901M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$823M |
| 5 |
Pinduoduo
PDD
|
+$770M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
Datadog
DDOG
|
+$747M |
| 3 |
TSMC
TSM
|
+$707M |
| 4 |
Baxter International
BAX
|
+$703M |
| 5 |
Estee Lauder
EL
|
+$592M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.28% |
| 2 | Healthcare | 10.85% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
Inovio Pharmaceuticals
INO
$69M
| $425K | ﹤0.01% |
43,231
-61,559
| -59% | -$1.05M |
|
5177
Weave Communications
WEAV
$423M
| $425K | ﹤0.01% |
85,522
+19,177
| +29% | +$96.4K |
|
5178
Cytosorbents Corp
CTSO
$22.6M
| $425K | ﹤0.01% |
125,977
+14,634
| +13% | +$43.9K |
|
|
EXAI
5179
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $423K | ﹤0.01% |
79,721
-242
| -0.3% | -$1.64K |
|
|
SSBK
5180
DELISTED
Southern States Bancshares
SSBK
| $422K | ﹤0.01% |
18,710
+11,531
| +161% | +$316K |
|
5181
NextNav
NN
$2.23B
| $421K | ﹤0.01% |
207,365
-2,292
| -1% | -$6.14K |
|
5182
Tonix Pharmaceuticals
TNXP
$192M
| $421K | ﹤0.01% |
36
+25
| +227% | +$429K |
|
|
TIG
5183
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $421K | ﹤0.01% |
68,745
-2,221
| -3% | -$13.5K |
|
5184
Alaunos Therapeutics
TCRT
$4.86M
| $418K | ﹤0.01% |
4,423
-5,043
| -53% | -$480K |
|
5185
Dimensional National Municipal Bond ETF
DFNM
$2.24B
| $416K | ﹤0.01% |
+8,619
| New | +$414K |
|
|
ENZ
5186
DELISTED
Enzo Biochem, Inc.
ENZ
| $415K | ﹤0.01% |
170,880
-196,422
| -53% | -$292K |
|
5187
National Bankshares
NKSH
$268M
| $415K | ﹤0.01% |
13,180
+8,060
| +157% | +$319K |
|
5188
Sanara MedTech
SMTI
$313M
| $414K | ﹤0.01% |
10,042
+4,907
| +96% | +$207K |
|
|
AFMD
5189
DELISTED
Affimed
AFMD
| $414K | ﹤0.01% |
55,533
-155,414
| -74% | -$1.55M |
|
|
LBC
5190
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $413K | ﹤0.01% |
43,552
-13,319
| -23% | -$148K |
|
5191
Symbotic
SYM
$5.22B
| $411K | ﹤0.01% |
18,010
+13,613
| +310% | +$228K |
|
5192
Dianthus Therapeutics
DNTH
$6.09B
| $411K | ﹤0.01% |
32,315
+27,334
| +549% | +$303K |
|
5193
Peoples Bancorp of North Carolina
PEBK
$229M
| $411K | ﹤0.01% |
12,933
+4,093
| +46% | +$134K |
|
|
RSF
5194
RiverNorth Capital and Income Fund
RSF
$58.9M
| $411K | ﹤0.01% |
27,149
-12,545
| -32% | -$196K |
|
5195
Prime Medicine
PRME
$559M
| $411K | ﹤0.01% |
33,385
+12,996
| +64% | +$212K |
|
5196
Vroom Inc
VRM
$48.2M
| $410K | ﹤0.01% |
5,700
+124
| +2% | +$10K |
|
5197
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$121M
| $409K | ﹤0.01% |
7,387
+9
| +0.1% | +$515 |
|
|
NOA
5198
North American Construction
NOA
$395M
| $408K | ﹤0.01% |
24,424
-42,719
| -64% | -$663K |
|
5199
Invesco S&P Spin-Off ETF
CSD
$228M
| $406K | ﹤0.01% |
7,181
-9,047
| -56% | -$512K |
|
5200
Janux Therapeutics
JANX
$967M
| $405K | ﹤0.01% |
33,504
+16,020
| +92% | +$267K |
|
Similar funds
Morgan Stanley's Q1 2023 Portfolio in Review
As of Q1 2023, Morgan Stanley held 8,043 positions worth $933B, up 5.9% from $880B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2023 filing shows 163 new, 3,525 increased, 3,121 reduced and 300 closed positions. Its largest new stake was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M. The largest sale was Apple, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2023 buy was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.62B increase.
- Morgan Stanley's biggest Q1 2023 reduction was Apple, cutting an estimated $1.19B.
- Morgan Stanley fully exited SVB Financial Group in Q1 2023, selling an estimated $354M.
- Morgan Stanley's ten largest holdings make up 16% of its $933B portfolio in Q1 2023.
- Morgan Stanley opened 163 new positions and closed 300 in Q1 2023.
- Morgan Stanley's portfolio value rose 5.9% quarter-over-quarter to $933B.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.